pharmaceutical investing Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July